Alopecia Market

DelveInsight’s ‘%Disease% - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted %Disease% epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017–2030


%Disease% Understanding

The DelveInsight %Disease% epidemiology report gives a thorough understanding of the %Disease% by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for %Disease% in the US, Europe, and Japan. The report covers the detailed information of the %Disease% epidemiology scenario in seven major countries (US, EU5, and Japan).


%Disease% Epidemiology Perspective by DelveInsight

The %Disease% epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The %Disease% epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The %Disease% epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


%Disease% Detailed Epidemiology Segmentation

The %Disease% epidemiology covered in the report provides historical as well as forecasted %Disease% epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight %Disease% report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The %Disease% report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The %Disease% Epidemiology Report and Model provide an overview of the risk factors and global trends of %Disease% in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of %Disease% in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of %Disease%
  • The report provides the segmentation of the %Disease% epidemiology


Report Highlights

  • 11-Year Forecast of %Disease% epidemiology
  • 7MM Coverage
  • Total Cases of %Disease%
  • Total Cases of %Disease% according to segmentation
  • Diagnosed cases of %Disease%


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to %Disease%?
  • What are the key findings pertaining to the %Disease% epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017–2030)?
  • What would be the total number of patients of %Disease% across the 7MM during the forecast period (2017–2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017–2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017–2030)?
  • What is the disease risk, burden and unmet needs of the %Disease%?
  • What are the currently available treatments of %Disease%?


Reasons to buy

  • The %Disease% Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global %Disease% market
  • Quantify patient populations in the global %Disease% market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for %Disease% therapeutics in each of the markets covered
  • Understand the magnitude of %Disease% population by its epidemiology
  • The %Disease% Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights

2. Executive Summary of Alopecia

3. Competitive Intelligence Analysis for Alopecia

4. Alopecia: Market Overview at a Glance

4.1. Alopecia Total Market Share (%) Distribution in 2017

4.2. Alopecia Total Market Share (%) Distribution in 2030

5. Alopecia: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms 

5.3. Pathophysiology 

5.4. Risk Factors 

5.5. Diagnosis 

6. Patient Journey

7. Alopecia Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Alopecia Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Alopecia Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Alopecia Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Alopecia Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Alopecia Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Alopecia Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Alopecia Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Alopecia Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Alopecia Treatment and Management

8.2. Alopecia Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Alopecia Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Alopecia: Seven Major Market Analysis

13.1. Key Findings

13.2. Alopecia Market Size in 7MM

13.3. Alopecia Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Alopecia Total Market Size in the United States

15.1.2. Alopecia Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Alopecia Total Market Size in Germany

15.3.2. Alopecia Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Alopecia Total Market Size in France

15.4.2. Alopecia Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Alopecia Total Market Size in Italy

15.5.2. Alopecia Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Alopecia Total Market Size in Spain

15.6.2. Alopecia Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Alopecia Total Market Size in the United Kingdom

15.7.2. Alopecia Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Alopecia Total Market Size in Japan

15.8.3. Alopecia Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Alopecia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

*The table of contents is not exhaustive; the final content may vary. 

Table 1 : 7MM Alopecia Epidemiology (2017-2030)

Table 2 : 7MM Alopecia Diagnosed and Treatable Cases (2017-2030)

Table 3 : Disease% Epidemiology in the United States (2017-2030)

Table 4 : Alopecia Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 : Alopecia Epidemiology in Germany (2017-2030)

Table 6 : Alopecia Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 : Alopecia Epidemiology in France (2017-2030)

Table 8 : Alopecia Diagnosed and Treatable Cases in France (2017-2030) 

Table 9 : Alopecia Epidemiology in Italy (2017-2030)

Table 10 : Alopecia Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 : Alopecia Epidemiology in Spain (2017-2030)

Table 12 : Alopecia Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 : Alopecia Epidemiology in the UK (2017-2030)

Table 14 : Alopecia Diagnosed and Treatable Cases in the UK (2017-2030)

Table 15 : Alopecia Epidemiology in Japan (2017-2030)

Table 16 : Alopecia Diagnosed and Treatable Cases in Japan (2017-2030)

Table 17 : Drug Name, Clinical Trials by Recruitment status

Table 18 : Drug Name, Clinical Trials by Zone

Table 19 : Total Seven Major Market Size in USD, Million (2017-2030)

Table 20 : Region-wise Market Size in USD, Million (2017-2030)

Table 21 : 7MM-Market Size by Therapy in USD, Million (2017-2030)

Table 22 : United States Market Size in USD, Million (2017-2030)

Table 23 : United States Market Size by Therapy in USD, Million (2017-2030)

Table 24 : Germany Market Size in USD, Million (2017-2030)

Table 25 : Germany Market Size by Therapy in USD, Million (2017-2030)

Table 26 : France Market Size in USD, Million (2017-2030)

Table 27 : France Market Size by Therapy in USD, Million (2017-2030)

Table 28 : Italy Market Size in USD, Million (2017-2030)

Table 29 : Italy Market Size by Therapy in USD, Million (2017-2030)

Table 30 : Spain Market Size in USD, Million (2017-2030)

Table 31 : Spain Market Size by Therapy in USD, Million (2017-2030)

Table 32 : United Kingdom Market Size in USD, Million (2017-2030)

Table 33 : United Kingdom Market Size by Therapy in USD, Million (2017-2030)

Table 34 : Japan Market Size in USD, Million (2017-2030)

Table 35 : Japan Market Size by Therapy in USD, Million (2017-2030)

*The list of tables is not exhaustive; the final content may vary

Figure 1 : 7MM Alopecia Epidemiology (2017-2030)

Figure 2 : 7MM Alopecia Diagnosed and Treatable Cases (2017-2030)

Figure 3 : Alopecia Epidemiology in the United States (2017-2030)

Figure 4 : Alopecia Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 : Alopecia Epidemiology in Germany (2017-2030)

Figure 6 : Alopecia Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 : Alopecia Epidemiology in France (2017-2030)

Figure 8 : Alopecia Diagnosed and Treatable Cases in France (2017-2030) 

Figure 9 : Alopecia Epidemiology in Italy (2017-2030)

Figure 10 : Alopecia Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 : Alopecia Epidemiology in Spain (2017-2030)

Figure 12 : Alopecia Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 : Alopecia Epidemiology in the UK (2017-2030)

Figure 14 : Alopecia Diagnosed and Treatable Cases in the UK (2017-2030)

Figure 15 : Alopecia Epidemiology in Japan (2017-2030)

Figure 16 : Alopecia Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 17 : Drug Name, Clinical Trials by Recruitment status

Figure 18 : Drug Name, Clinical Trials by Zone

Figure 19 : Total Seven Major Market Size in USD, Million (2017-2030)

Figure 20 : Region-wise Market Size in USD, Million (2017-2030)

Figure 21 : 7MM-Market Size by Therapy in USD, Million (2017-2030)

Figure 22 : United States Market Size in USD, Million (2017-2030)

Figure 23 : United States Market Size by Therapy in USD, Million (2017-2030)

Figure 24 : Germany Market Size in USD, Million (2017-2030)

Figure 25 : Germany Market Size by Therapy in USD, Million (2017-2030)

Figure 26 : France Market Size in USD, Million (2017-2030)

Figure 27 : France Market Size by Therapy in USD, Million (2017-2030)

Figure 28 : Italy Market Size in USD, Million (2017-2030)

Figure 29 : Italy Market Size by Therapy in USD, Million (2017-2030)

Figure 30 : Spain Market Size in USD, Million (2017-2030)

Figure 31 : Spain Market Size by Therapy in USD, Million (2017-2030)

Figure 32 : United Kingdom Market Size in USD, Million (2017-2030)

Figure 33 : United Kingdom Market Size by Therapy in USD, Million (2017-2030)

Figure 34 : Japan Market Size in USD, Million (2017-2030)

Figure 35 : Japan Market Size by Therapy in USD, Million (2017-2030)

*The list of figures is not exhaustive; the final content may vary.

  • Tags:
  • Alopecia market
  • Alopecia market research
  • Alopecia market insight
  • Alopecia market trends
  • Alopecia market forecast
  • Alopecia market share
  • Alopecia pipeline drugs
  • Alopecia treatment algorithm
  • Alopecia drugs
  • Alopecia sales forecasting
  • Alopecia market size
  • Alopecia disease
  • Alopecia epidemiology
  • Alopecia

Forward to Friend

Need A Quote